| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing only metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only diloxanide and metronidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only metronidazole in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only metronidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only metronidazole in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 10 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 10 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 1 g rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 1 g rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely furazolidone 6 milligram/1 milliliter and metronidazole (as metronidazole benzoate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing furazolidone and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Furazolidone and metronidazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only furazolidone and metronidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Furazolidone- and metronidazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 2.5 milligram/1 gram and metronidazole 10 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorhexidine gluconate 2.5 milligram/1 gram and metronidazole 10 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing chlorhexidine and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chlorhexidine and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine- and metronidazole-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chlorhexidine and metronidazole in dental dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing lidocaine and metronidazole and sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only lidocaine and metronidazole and sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Furazolidone 100 mg and metronidazole 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Furazolidone 100 mg and metronidazole 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
2 |
| Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Diloxanide furoate 250 mg and metronidazole 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 500 mg vaginal pessary |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 500 mg vaginal pessary |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]